tradingkey.logo

STRATA Skin Sciences Inc

SSKN
View Detailed Chart

1.570USD

+0.020+1.29%
Close 09/19, 16:00ETQuotes delayed by 15 min
6.55MMarket Cap
LossP/E TTM

STRATA Skin Sciences Inc

1.570

+0.020+1.29%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.29%

5 Days

0.00%

1 Month

-14.21%

6 Months

-39.85%

Year to Date

-46.05%

1 Year

-46.96%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
91 / 207
Overall Ranking
204 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
8.000
Target Price
+416.13%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.56M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 81.76.
Overvalued
The company’s latest PE is -0.55, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.84M shares, increasing 0.78% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 98.03K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 16.43.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Ticker SymbolSSKN
CompanySTRATA Skin Sciences Inc
CEODr. Dolev Rafaeli
Websitehttps://www.strataskinsciences.com/
KeyAI